In late November, the drugmaker filed suit against two Florida compounding pharmacies, Wells Pharmacy and Brooksville Pharmaceuticals, alleging they sell semaglutide therapies containing impurities up to 33% of the product.
The lawsuits are the latest in a series of litigation across the U.S. In June, Novo Nordisk filed lawsuits against six spas and clinics, and the next month saw filed suits against three compounding pharmacies.
The FDA is currently investigating schemes that sell counterfeit versions of Ozempic to unsuspecting pharmacies.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
